• Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy

  • 2025/04/25
  • 再生時間： 53 分
  • ポッドキャスト

Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Featuring an interview with Dr Adam M Brufsky, including the following topics:

    • Case: A woman in her early 50s with ER-positive, HER2-low de novo metastatic breast cancer (0:00)
    • Case: A woman in her late 70s with ER-positive, HER2-low metastatic breast cancer after 5 years of an adjuvant aromatase inhibitor (6:52)
    • Clinical Investigator Survey Results (10:05)

    CME information and select publications
    続きを読む 一部表示

あらすじ・解説

Featuring an interview with Dr Adam M Brufsky, including the following topics:

  • Case: A woman in her early 50s with ER-positive, HER2-low de novo metastatic breast cancer (0:00)
  • Case: A woman in her late 70s with ER-positive, HER2-low metastatic breast cancer after 5 years of an adjuvant aromatase inhibitor (6:52)
  • Clinical Investigator Survey Results (10:05)

CME information and select publications
続きを読む 一部表示

Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapyに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。